CBP and SRF co-regulate dendritic growth and synaptic maturation by Blanco, Beatriz del et al.
Cell Death & Differentiation (2019) 26:2208–2222
https://doi.org/10.1038/s41418-019-0285-x
ARTICLE
CBP and SRF co-regulate dendritic growth and synaptic maturation
Beatriz del Blanco1 ● Deisy Guiretti1,2 ● Romana Tomasoni1,3 ● María T. Lopez-Cascales1 ● Rafael Muñoz-Viana1 ●
Michal Lipinski1 ● Marilyn Scandaglia1 ● Yaiza Coca1 ● Román Olivares1 ● Luis M. Valor1,4 ● Eloísa Herrera1 ●
Angel Barco1
Received: 27 August 2018 / Revised: 17 December 2018 / Accepted: 10 January 2019 / Published online: 8 March 2019
© The Author(s) 2019. This article is published with open access
Abstract
The CREB-binding protein (CBP) exerts tight control of developmental processes. Here, we investigated the consequences
of its selective ablation in newborn neurons. Mice in which CBP was eliminated during neuronal differentiation showed
perinatal death and defective diaphragm innervation. Adult-born neurons also showed impaired growth and maturation after
inducible and restricted CBP loss in dentate gyrus neuroprogenitors. Consistent with these in vivo findings, cultured neurons
displayed impaired outgrowth, immature spines, and deficient activity-dependent synaptic remodeling after CBP ablation.
These deficits coincided with broad transcriptional changes affecting genes involved in neuronal growth and plasticity. The
affected gene set included many predicted targets of both CBP and the serum response factor (SRF), an activity-regulated
transcription factor involved in structural plasticity. Notably, increasing SRF activity in a CBP-independent manner
ameliorated the transcriptional, synaptic, and growth defects. These results underscore the relevance of CBP–SRF
interactions during neuronal outgrowth and synaptic maturation, and demonstrate that CBP plays an essential role in
supporting the gene program underlying the last steps of neuronal differentiation, both during development and in the
adult brain.
Introduction
Impaired neuronal maturation, including alterations in den-
drite branching and spine morphology and density, is a
feature of many neurodevelopmental disorders (NDDs) [1, 2].
One of such syndromes is the Rubinstein–Taybi syndrome
(RSTS, OMIM #180849) [3, 4], a congenital autosomal-
dominant NDD that is caused by hemizygous mutations in
CREBBP in most patients [5]. This gene encodes the
CREB-binding protein (CBP, aka KAT3a), a large protein
with intrinsic lysine acetyltransferase (KAT) activity that
functions as a transcriptional co-activator for numerous
transcription factors (TFs) [6]. Because of its dual roles as a
molecular scaffold for the assembly of multimeric protein
complexes at regulatory regions and a KAT for histones and
other nuclear proteins, CBP is uniquely positioned to con-
trol the establishment of novel gene programs during
development.
The early embryonic death of CBP null embryos at E10
due to a failure of the neural tube to close has prevented the
precise examination of the role of CBP in neuronal differ-
entiation and maturation [7]. In contrast, when CBP is
eliminated in mature neurons in the postnatal brain, gross
neurological defects and neurodegeneration are not
observed, but restricted deficits in specific forms of memory
have been reported [8–10]. The comparison of CBP hemi-
zygous mice, which present many traits associated with
RSTS [11, 12], and the comparatively milder phenotype of
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postnatal neuronal-restricted knockouts indicates that CBP
is not only critically required during central nervous system
(CNS) development [13–16], but plays a more confined role
in mature neurons [17].
Here, we generated mice lacking CBP in newborn neurons
by crossing Crebbpf/f mice [18] with transgenic lines that
express the Cre recombinase (either conventional or tamox-
ifen-regulated) under the control of the nestin promoter to
precisely investigate the role of CBP in neuronal differentia-
tion and maturation. Ex vivo and in vivo morphological
analyses demonstrated that the loss of CBP in hippocampal
neurons interfered with dendrite outgrowth, spine maturation,
and chemically induced long-term potentiation (cLTP). Fur-
thermore, RNA-seq data linked these phenotypes with
defective activation of transcriptional programs involved in
dendritogenesis, synaptogenesis, and synaptic activity. In
particular, genes downstream of the serum response factor
(SRF) related to neuronal growth and activity-dependent
plasticity [19] were affected. This activity-regulated TF is
known to participate in transcriptional complexes that contain
CBP [20, 21]. Notably, the expression of a constitutively
active SRF protein with the ability to transactivate target
genes in a CBP-independent manner reduced the growth and
transcriptional defects associated with CBP ablation. Based
on these results, we conclude that CBP, and in particular its
interaction with SRF, is required in newborn neurons to
activate the gene program that underlies dendritic growth,
spine maturation, and activity-dependent synaptic changes.
Results
The loss of CBP in newborn neurons causes
perinatal death due to impaired diaphragm
innervation
We crossed CBP floxed mice (Crebbpf/f) with Nestin-cre
transgenics to produce neural-specific conditional
knockouts (cKOs) and investigate the consequences of
selective CBP elimination in recently born neurons
(Fig. 1a). Previous investigations using this Cre-driver
line have reported insufficient Cre recombinase expres-
sion for gene ablation in early embryonic neural pro-
genitors, while recombination becomes efficient during
late embryonic and early postnatal periods [22]. This Cre-
driver is therefore adequate to investigate the specific
impact of gene ablation on newborn neurons. The off-
spring of these crossings were produced in the expected
Mendelian ratios at birth (Fig. 1a). However, the newborn
Nestin-Cre:Crebbpf/f pups (hereafter referred to as Nes-
cKOs) rapidly showed respiratory distress, became cya-
notic and died in the first hour of life (Fig. 1a). The
autopsy of Nes-cKO pups revealed pulmonary collapse,
possibly due to respiratory failure, in the absence of any
apparent malformation in the heart, kidneys, brain, and
other major organs (Fig. 1b and data not shown). How-
ever, a 3D reconstruction of magnetic resonance images
(MRI) revealed significantly smaller hippocampi in
homozygous mice than in control littermates. As expec-
ted, the loss of CBP in the neurons caused a reduction in
KAT activity reflected in the hypoacetylation of specific
histone substrates, such as histone H2B, in the brain of P0
Nes-cKO pups (Fig. 1c). Since the autopsy suggested
possible respiratory failure, we next investigated dia-
phragm innervation. Whole-mount diaphragms were
stained with an antibody against neurofilament (NF). In
control diaphragms, primary phrenic branches extended
numerous secondary or intramuscular branches that
formed neuromuscular junctions close to the primary
branches. Motor axon projections and branches were
underdeveloped in diaphragms from Nes-cKO pups
(Fig. 1d), confirming that the innervation defects were a
likely cause of the perinatal death. Thus, conditional CBP
ablation in this strain does not interrupt embryonic
development, but severely decreases survival after birth.
Adult–newborn neurons lacking CBP also show
abnormal maturation
We next investigated if CBP loss affected the maturation
and outgrowth of adult-born hippocampal neurons in the
same manner as embryonic-born neurons. To this end, we
generated Nestin-CreERT2:Crebbpf/f mice. This inducible
KO strain (referred to as Nes-iKO) exhibits a loss of CBP
immunoreactivity in newborn granule neurons in the den-
tate gyrus a few days after tamoxifen (TMX) administration.
We also introduced an allele that drives the expression of
the red fluorescent protein tdTomato (tdTOM) in a Cre-
recombination-dependent manner to facilitate the morpho-
logical analyses (Fig. 2a). This reporter construct enables
monitoring of the maturation and integration in adult neu-
ronal circuit of newborn neurons. TMX administration in
P60 mice resulted in simultaneous CBP ablation and red
fluorescence-labeling of the neurons born at the time of
administration; we then waited for 4 weeks for maturation
of the labeled adult–newborn neurons (Fig. 2b).
Although the loss of CBP did not significantly reduce
the number of tdTOM-positive (tdTOM+) cells (Fig. 2c),
tdTOM+ cells displayed abnormal dendritic morphology
and were mispositioned in the granule cell layer (Fig. 2d).
We co-stained brain sections with the immature neuron
marker doublecortin (Dcx) and the mature neuron marker
NeuN to characterize these abnormal cells. More cells
exhibited co-localization of Dcx and tdTOM in Nes-iKO
mice than in control littermates (Fig. 2e, f), whereas the
co-localization of tdTOM with the marker NeuN was
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reduced (Fig. 2g, h). Together, these quantitative analyses
indicate a delay or inhibition of the differentiation of the
newborn cells (Fig. 2i). These findings are consistent with
our observations in Nes-cKO mice and underscore the
importance of CBP in the last steps of neuronal differ-
entiation, both during early postnatal development and in
the adult brain.
Cultured neurons lacking CBP show impaired
dendritic growth and synaptogenesis
To obtain additional mechanistic insight into the role of
CBP during neuronal maturation, we next investigated
whether CBP loss affected neuronal outgrowth ex vivo
using primary neuronal cultures (PNCs). Consistent with
the atrophy observed in the MRI volumetric analysis, fewer
cells were obtained from the hippocampi of Nes-cKO
embryos than control littermates (numbers of cells: WT=
533 K ± 50.0; Nes-KO= 368 K ± 47.5; n= 7 embryos per
genotype; p= 0.03 unpaired Student’s t test). Ten days after
plating, an equal number of E17 hippocampal cells,
immunostaining experiments confirmed the loss of CBP
immunoreactivity (Fig. 3a) and the hypoacetylation of
several lysine residues in the histone tails. As shown in vivo
(Fig. 1c) and in several previous studies [9, 11, 23], H2B
was particularly affected (Fig. 3b, c). Double staining of
Fig. 1 The loss of CBP in newborn neurons causes perinatal death due
to innervation failure and reduced neuronal production. a Left panel:
schematic of the genetic strategy and breeding results. Nestin-Cre:
Crebbpf/+ mice were crossed with Crebbpf/f mice; the offspring of
these crosses included cWT (no Cre:Crebbpf/f and no Cre:Crebbp+/f,
both genotypes are included in the control group), Nes-cHet (Nestin-
Cre:Crebbpf/+), and Nes-cKO (Nestin-Cre:Crebbpf/f) embryos. Right
panel: the bar graphs show the normal Mendelian distribution of
genotypes among newborns and embryos that is disrupted after birth
due to the perinatal death of Nes-cKO pups (n= 20 litters). b Top:
Nes-cKO pups do not show any apparent malformation in the brain.
Scale bars: left panel, 1 mm; right panel, 500 μm. Bottom: hippo-
campal volumes were smaller in Nes-cKO pups than in control
littermates (n= 3 pups). Student's t test: *P < 0.05. c Immuno-
fluorescence staining showing CBP loss and histone H2B hypoace-
tylation in the hippocampus and cortex of Nes-cKO pups. Scale bars:
100 μm (hippocampus) and 10 μm (cortex). d Diaphragm innervation
defects in Nes-cKO pups. Representative images of the immunos-
taining of the phrenic nerve innervation (right side) with anti-pan-
axonal neurofilament antibody (n= 3 pups). Scale bar: 1 mm
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Nes-cKO and control cultures with antibodies against the
neuron-specific cytoskeletal protein MAP2 and the astro-
cyte marker GFAP showed no difference in GFAP staining
(Fig. 3d), whereas MAP2 staining revealed dramatic dif-
ferences in neuronal morphology (Fig. 3e and e’). We
transfected DIV9 cultures with a GFP-expressing construct
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under the control of the neuronal-specific synapsin promoter
(syn-GFP) to precisely investigate the morphological
changes occurring during the maturation of cultured neu-
rons. After 24 h, we fixed the cells and quantified the den-
drite length and number. The dendritic tree in neurons from
Nes-cKO embryos was shorter and less complex than in
control neurons, indicating that the ablation of CBP affects
the ability of cultured neurons to elaborate a dendritic tree
(Fig. 3f, g). Interestingly, these differences in neurite
growth were ameliorated by increasing the concentration of
trophic factors in the culture medium and aggravated upon
decreasing their levels (Fig. 3h). Thus, CBP-deficient neu-
rons may not have an intrinsic growth defect but an
impaired response to neurotrophic factors.
To further explore the effects of CBP loss on hippo-
campal neurons, we examined synaptic density and mor-
phology. We transfected the cultures of Nes-cKO and wild-
type embryos with syn-GFP at DIV14 and waited for 48 h
before cell fixation and the analysis of the morphology of
dendritic spines. Although the synaptic density was similar
in both genotypes (Fig. 3i), we detected an increase in the
proportion of immature, thin spines (filopodia-like) in cul-
tures from Nes-cKO embryos compared with controls,
whereas the number of mature spines (mushroom-shaped)
was reduced (Fig. 3j). These data indicate that synaptic
maturation is also impaired in CBP-deficient neurons.
A transcriptome analysis identifies CBP target genes
in maturing neurons
We conducted next an RNAseq-based screen to compare
the transcriptomes of Nes-cKO and control (produced from
littermate embryos) DIV10 cortical PNCs and identify the
transcriptional defects that underlie the phenotypes caused
by CBP loss. Our stringent filtering criteria retrieved 496
differentially expressed genes (DEGs) in Nes-cKO cultures
(Table S1, see Fig. S1A-B for quality controls). Consistent
with the role of CBP as a transcriptional co-activator, most
of the changes corresponded to downregulated genes
(Fig. 4a). Among the downregulated genes, we identified
genes encoding the postsynaptic protein neurogranin
(Nrgn), the Wnt-signaling protein Wnt7b (Fig. 4b), and
many other biologically relevant neuronal genes. Gene
ontology (GO) analyses revealed that downregulated DEGs
were related to functions, such as Generation of neurons,
Synaptic signaling, Synaptic transmission, and Neuron
projection development (Fig. 4c and Fig. S1C).
The large number of downregulated genes related to
synaptic function suggest that the transcriptional program
induced by synaptic activity may be impaired in Nes-cKO
neurons. To tackle this hypothesis, we stimulated neuronal
cultures with bicuculline (Bic), an antagonist of GABAA
receptors, which causes both presynaptic and postsynaptic
activation. As expected, Bic stimulation of DIV10 cWT
neurons induced the expression of immediate early genes
(IEGs) involved in synaptic plasticity, such as Npas4, Fosb,
and Bdnf (Fig. 4d and Table S2). In contrast, Nes-cKO
neurons were unable to trigger these transcriptional changes
after Bic stimulation (Fig. 4e and Table S3). Overall, Bic
stimulation exacerbated the differences between the Nes-
cKO and control transcriptome both in term of number and
magnitude of the changes (Fig. 4f). The negative impact on
neuronal plasticity and growth pathways was particularly
prominent (comparison of the data presented in Figs. 4c, g).
For instance, the activity-dependent production of key
plasticity-related factors, such as the brain-derived neuro-
trophic factor (Bdnf) and neuronal pentraxin (Nptx2) [24],
was blocked in the absence of CBP (Fig. 4h).
We next conducted a time course analysis of selected
target genes using independent RT-qPCR assays to evaluate
the impairments in activity-driven transcription in greater
detail (Fig. 4i). These experiments confirmed both the
downregulation in the basal state and the deficient induction
upon stimulation observed in Nes-cKO neurons in our
RNAseq screen. These results are consistent with the
hypothesis that CBP is actively recruited to transcriptional
regulatory elements upon synaptic activation and is essen-
tial for activity-dependent neuronal maturation.
Impaired activity-induced structural changes in Nes-
cKO neurons
Since the gene sets downregulated upon CBP ablation,
both at baseline and after neuronal activation, are related
to synaptic functions, we next investigated whether
activity-dependent synaptic maturation was impaired in
CBP-deficient neurons. To address this question, we used
a well-established protocol for chemical induction of
long-term potentiation (cLTP), in which hippocampal
Fig. 2 Adult-born neurons lacking CBP also show impaired growth.
a Schematic of genetic strategy used to deplete CBP in neuropro-
genitor cells in the adult brain. b Immunostaining with anti-CBP to
verify the loss of CBP in adult-born neurons 4 weeks after TMX
administration. Scale bar: 10 μm. c Quantification of tdTOM cells.
d The 3D reconstruction of dendritic branches shows a dendritic defect
in adult-born granular cells in the dentate gyrus of Nes-iKO mice.
Scale bars: lef panel, 200 μm; right panel, 20 μm. e, f Quantification of
the number of Dcx+ cells among tdTOM-expressing cells (e) and
representative images of immunostaining with anti-Dcx antibodies in
Nes-iKO and control littermates (f). Scale bars: lef panel, 200 μm; right
panel, 20 μm. g, h Quantification of the number of NeuN+ cells among
tdTOM-expressing cells (g) and representative images of immunos-
taining with anti-NeuN antibodies in Nes-iKO and control littermates
(h). Scale bars: left panel, 200 μm; right panel, 50 μm. i Percentages of
tdTOM-expressing cells positive for Dcx and NeuN. The upper
scheme summarizes the expression of Dcx and NeuN markers during
adult neurogenesis
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neurons are exposed to a high dose of glycine for 3 min
followed by washout and recovery in neuronal medium
for at least 60 min [25]. As described above, we trans-
fected the PNCs of Nes-cKO and wild-type embryos with
syn-GFP 48 h before fixing the cells to visualize the
morphology of dendritic spines. Afterwards, we observed
a significant increase in the density of spines on wild-type
neurons (Fig. 4j), primarily mushroom and stubby spines
Fig. 3 Cultured neurons lacking CBP show impaired dendritic growth and synaptogenesis. a Immunofluorescence staining showing CBP loss in
cultured Nes-cKO hippocampal neurons at day DIV10. Scale bar: 50 μm. b Immunostaining for histone acetylation marks (H3ac, H4ac, H2Bac,
and H2Aac) reveals a decrease in the level of acetylation in Nes-cKO PNCs at day DIV10. Scale bar: 50 μm. c Quantification of the immu-
nostaining for histone acetylation in PNCs at day DIV10 (n= 3 independent PNCs). d–f Hippocampal neurons transfected with syn-GFP were
stained for GFAP (d), MAP2 (e and e’) and GFP (f). The same fields are shown in the different pictures. Scale bar: 25 μm. g Sholl analysis
presenting the number of intersections versus distance to soma. Error bars are shown every 2 μm. Statistically significant differences between
genotypes were analyzed using two-way ANOVA (not repeated measures), ****P < 0.0001 (n= 4–5 neurons from three independent PNCs). h
The concentration of trophic factors in the culture media modulates the growth defect in Nes-cKO neurons. Order range (OR): 1–8 correspond to
initial dendrites; 9–16 to intermedial dendrites; and 17–32 or higher to terminal dendrites. i, j Quantification of spine density (i; spines/μm of
dendrite length) and morphology (j) in Nes-cKO and control hippocampal neurons at DIV16. Student's t test; *P < 0.05, **P < 0.01, and ***P <
0.001; n= 6–8 neurons from independent PNCs
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(Fig. 4k, l). However, this increase was not observed in
Nes-cKO neurons (Fig. 4j, l), indicating that neurons
lacking CBP are unable to undergo activity-dependent
synaptic changes.
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Enhancing the SRF-dependent transcription of
neuronal growth-related genes reverses the dendritic
and synaptic deficits associated with CBP loss
CBP is a co-factor for many TFs regulating neuronal gene
expression [6, 26]. We conducted a TF-binding site (TFBS)
enrichment analysis using the promoters of genes that failed
to be induced in Nes-cKO neurons after Bic stimulation to
identify the transcriptional complexes that were altered in
Nes-cKO neurons. This screen retrieved a number of TFs that
are known to be stimulus-regulated and are involved in
neuronal plasticity (Fig. S2A-B). Among these TFs, we
decided to focus on SRF for several reasons: (i) this TF
presented the largest enrichment in our TFBS analysis; (ii)
this stimulus-regulated TF has been shown to be an essential
component in the transcriptional machinery that regulates
dendritic growth and synaptogenesis [27, 28] (iii) classical co-
immunoprecipitation and luciferase reporter experiments [20,
29] and genomic screens [30] indicate that CBP may coop-
erate with SRF in binding to activity-regulated promoters and
enhancers; and (iv) the amelioration of outgrowth defects in
Nes-cKO PNCs by trophic factors (Fig. 3h) suggests that
signal transduction cascades upstream of SRF may be
involved in the deficits observed in CBP-deficient neurons.
To examine the contribution of impaired formation of
CBP–SRF complexes to outgrowth and transcriptional
defects, we tested whether enhancing SRF-dependent tran-
scription in a CBP-independent manner reversed or ame-
liorated the deficits. Toward this end, we used a lentiviral
vector that expresses a constitutively active variant of SRF,
in which the VP16 transactivation domain of Herpes sim-
plex virus (HSV) is fused to the DNA-binding domain of
SRF (Fig. 5a). This chimeric protein, referred to as VP16-
SRF, enables the direct recruitment of the RNA polymerase
II complex to available SRF-binding sites bypassing CBP
requirements [31]. Previous investigations in our laboratory
have confirmed that this chimeric protein enhances the
transcription of genes involved in neuronal growth [28].
Notably, 22% of the genes identified in our previous study
are differentially expressed in Nes-cKO neurons, and those
genes are involved in synaptic plasticity, dendritogenesis,
and neurogenesis (Fig. S2C).
To assess the effect of VP16-SRF expression on CBP-
deficient neurons, we first examined whether the expression
of relevant DEGs downstream of SRF was enhanced by
VP16-SRF. RT-qPCR experiments confirmed their upre-
gulation in both control and Nes-cKO neurons (Fig. 5a).
Next, to investigate the mechanism underlying this rever-
sal, we determined the genomic occupancy profile of
VP16-SRF in hippocampal neurons by ChIP-seq using an
antibody that recognizes the VP16 domain. VP16-SRF
binds to more than 10,000 regions in hippocampal chro-
matin, which are associated with 5911 genes (Table S4)
and are preferentially located at distal intergenic and
intronic regions (Fig. S2D). Notably, 85% of the genes
associated with VP16-SRF peaks also showed CBP occu-
pancy according to the CBP-binding profile in hippo-
campal chromatin produced in our laboratory (Fig. S2E), a
percentage of overlap much larger than the one expected by
chance (p-value= 7.44 × 10−69, exact hypergeometric
probability test). Moreover, VP16-SRF and CBP bind at
the same genomic location in 2348 genes (47% of co-
occupied genes; Fig. S2F). This high level of coincidence
suggests that these genes are co-regulated by SRF and
CBP. Consistent with this hypothesis, many of the genes
deregulated in CBP-deficient neurons (35% of DEGs in
non-stimulated neurons and 45% of DEGs in Bic-
stimulated neurons) showed VP16-SRF binding (Fig. 5b).
We next compared the ChIP signal for VP16-SRF with
genomic occupancy profiles for SRF in non-stimulated and
in KCl-stimulated primary cortical cultures [30] to test if
this chimeric protein binds to the same sites as the endo-
genous SRF. Despite the very low genomic coverage in the
seminal ChIP-seq experiments by Kim et al., we observed a
large overlap with our VP16-SRF profiles under both
conditions (48% in non-stimulated cells and 50% in sti-
mulated cells; Fig. 5c). The intersection of the three ChIP-
seq profiles was occupied by 811 genes, which we consider
bona fide targets of SRF in cultured neurons. Supporting
the hypothesis that the deregulation of genes dependent on
CBP–SRF complexes is responsible for the phenotype of
Nes-cKO neurons, 418 bona fide targets of SRF displayed
overlapping VP16-SRF and CBP binding (Fig. 5c, inset).
Furthermore, this gene set was highly enriched in genes
involved in biological processes, such as neuron develop-
ment and differentiation, and neuron projection develop-
ment and morphogenesis, which are strongly correlated
Fig. 4 Impaired activity-induced transcription and structural changes
in Nes-cKO neurons. a Analysis of the transcriptomes of DIV10 Nes-
cKO and wild-type hippocampal cultures. Most of these changes
corresponded to downregulated genes (green dots; p-adj < 0.1, abs
(L2FC) > 0.3). b RNA-seq profiles for representative downregulated
genes in Nes-cKOs. c Gene ontology (GO) analysis of biological
processes enriched in downregulated genes in Nes-cKO PNCs under
basal conditions (non-stimulated). d Volcano plot corresponding to
DEGs between non-stimulated and Bic-stimulated (2.5 h after treat-
ment) cortical cWT PNCs. e Volcano plot corresponding to DEGs
between non-stimulated and Bic-stimulated (2.5 h after treatment)
cortical Nes-cKO PNCs. f Distribution graph comparing DEGs
between genotypes in non-stimulated and stimulated PNCs. g GO
analysis of downregulated genes upon stimulation. h RNA-seq profiles
for representative activity-regulated genes. i Time course analysis of
the induction of selected IEG using RT-qPCR. j, k Activity-dependent
synaptogenesis (j) and synaptic maturation (k) are impaired in CBP-
deficient neurons. l Representative images of activity-dependent
structural changes in spines 60 min after cLTP induction in Nes-
cKO and cWT hippocampal neuronal cultures
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with the reported phenotypes (Fig. 5d). Some examples of
DEGs that are involved in these processes and co-regulated
by CBP and SRF in non-stimulated and Bic-stimulated
PNCs are shown in Fig. 5e and S2G-H.
Finally, we tested whether the CBP-independent
enhancement of SRF transcription ameliorated or reversed
the outgrowth defect in Nes-cKO neurons to directly assess
the relevance of the gene program downstream of SRF–CBP
complexes. Sholl analyses revealed an increase in the length
of intermediate and terminal dendrites of Nes-cKO neurons
after infection with VP16-SRF compared with VP16 control
(Fig. 5f). Notably, infection with VP16-SRF also restored the
number of mature and intermediate spines and simultaneously
decreased the number of immature spines (Fig. 5g). Further-
more, activity-dependent synaptic deficits were also reduced.
Thus, the number of mushroom spines observed after 60min
of cLTP was increased in Nes-cKO neurons after infection
with VP16-SRF compared with controls (Fig. 5h, i). Based on
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these results, the SRF–CBP transcriptional complex plays a
critical role during neuronal maturation by regulating pro-
cesses, such as dendritogenesis, synaptogenesis, and activity-
depending synaptic remodeling.
Discussion
CBP is known to regulate cell lineage differentiation during
early development [32]. At later stages, it is also involved in
regulating the differentiation of a variety of neural cell types,
such as motoneurons, cortical progenitors, and astrocytes
[14, 16, 17, 33, 34]. However, the consequences of its elim-
ination in forebrain principal neurons at the time of neuronal
differentiation and maturation had not been explored.
Nes-cKO mice represent an ideal model to investigate
the role of CBP during neuronal differentiation and
maturation in vivo. These mice showed a reduced hippo-
campal volume, impaired dendritic growth, and immature
synapses with concomitant hypoacetylation at nucleosome
histones, indicating that CBP is essential at this stage of
neuronal development. The experiments in Nes-iKO mice
and CBP-deficient PNCs further confirmed this view and
revealed that the loss of CBP also interfered with the
expression of mature neuron markers in the adult brain and
in cultured neurons. Underscoring the clinical relevance of
these findings, a recent study has reported the abnormal
morphology of neurons derived from induced pluripotent
stem cells (aka iNeurons) from selected patients with RSTS
(who bear mutations in either CREBBP or EP300), although
the magnitude of the anomalous neuronal morphology
varied among patients [4]. The results presented here,
together with previous findings by other researchers and our
group, indicate that the cognitive and neurological deficits
associated with RSTS [11] have three distinct components:
the first one originates during the embryonic development
of the CNS and is related to the epigenetic programming of
cell identity [35]; the second is derived from the impaired or
delayed neuronal maturation, as reported here; and the third
results from the continuous requirement for the enzymatic
activity of CBP throughout life [8–10, 36].
We specifically assessed here the impact of enhancing
SRF-driven transcription to rescue the second type of deficit.
Several lines of evidence support a functional interaction
between SRF, an important regulator of adaptive responses
that involve changes in neuronal morphology [19], and CBP.
For instance, studies in mice with a conditional loss of SRF in
neurons revealed defects in LTP, but no impairment in neu-
ronal survival [37, 38], which is also observed in CBP-
deficient mice [11]. Co-immunoprecipitation experiments and
co-transfections of CBP with serum-responsive reporter
plasmids indicate that CBP cooperates with SRF and suggest
that both proteins are part of the same multimolecular com-
plex [20]. The physical interaction between SRF and CBP has
been further confirmed by two-hybrid assays in mammalian
cells [21]. Moreover, SRF-mediated induction of the IEG Fos
is potentiated by the recruitment of CBP by the ternary
complex factor Elk-1 [29]. Based on these findings, CBP was
proposed to constitutively bind to the SRE in a higher order
complex, which would facilitate the rapid transcriptional
activation [29]. Our results are consistent with this model and
show for the first time the relevance of SRF–CBP interactions
in newborn neurons. According to our results, CBP–SRF
transcriptional complexes play an essential role in the late
stages of neuronal maturation by affecting dendritogenesis,
synaptogenesis, and activity-dependent synaptic maturation.
Moreover, our results suggest that strategies designed to
enhance SRF signaling in early postnatal stages represent a
potentially promising therapeutic approach for preclinical
models of RSTS by intervening in the impaired CBP-
dependent neuronal growth and synaptic maturation.
Materials and methods
Mouse strains
Crebbpf/f [18], CMV-fxSTOPfx-tdTomato (tdTOM) [39],
Nestin-Cre [40], and Nestin-Cre-ERT2 [41] strains have been
Fig. 5 Enhancing SRF-dependent transcription of neuronal growth-related
genes reverses the synaptic deficits associated with CBP loss. a The upper
scheme shows the lentiviral (LV) constructs and color code used in the
rescue experiments. LTR long-termination repeats, SynP synapsin pro-
moter, WPRE woodchuck hepatitis virus post-transcriptional regulatory
element. The lower bar graphs show RNA levels of two relevant DEGs
that were upregulated upon VP16-SRF expression. b Venn diagram pre-
senting the overlap between VP16-SRF target genes and DEGs in Nes-
cKO neurons. The right graph shows the percentage of DEGs in non-
stimulated (DEG-NS) and stimulated (DEG-Bic) PNCs that bind VP16-
SRF. c Venn diagram presenting the overlap between VP16-SRF-bound
genes and endogenous SRF binding (based on SRF occupancy profiles
reported by Kim et al. 2010). The right inset shows the overlap between
bona fide SRF targets and genes that bind to both VP16-SRF and CBP.
d GO graph summarizing the biological processes enriched in the gene set
presenting co-occupancy for both CBP and VP16-SRF. e IGV snapshots
showing the co-localization of CBP and VP16-SRF at regulatory regions
in two representative DEGs in non-stimulated (left panel) and Bic-
stimulated PNCs (right panel). f VP16-SRF-infected PNCs were trans-
fected with dsRed to unveil the morphology of individual neurons. The
Sholl analysis revealed an increase in the length of the primary and sec-
ondary dendrites from Nes-cKO neurons infected with VP16-SRF. *P <
0.05. g Rescue of synaptic maturation defects in Nes-cKO neurons by
VP16-SRF expresion. VP16-infected Nes-cKO neurons were used as a
control. h Quantification of the number of mushroom spines before and
after 60min of cLTP in VP16-SRF and VP16-infected Nes-cKO neurons.
i Representative images of activity-dependent synaptic changes in VP16-
SRF and VP16-infected Nes-cKO neurons
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described previously. The last three strains are available at the
Jackson laboratory with the stock numbers #7914, #3771 and
#16261, respectively, while the first strain was provided by
Beat Lutz’ lab (Institute of Molecular Biology, Mainz, Ger-
many). Note that both Nestin-Cre and Nestin-Cre-ERT2 mice
express the Cre recombinase under the control of the Nestin
promoter, but in the second case recombination is controlled
by TMX-induced nuclear translocation of a chimeric recom-
binase [41]. In the experiments using Nestin-Cre-ERT2,
recombination was triggered by TMX administration when
the mice were 8-week-old (intragastric delivery of 200mg/kg
dissolved in 100% corn-oil for 5 alternative days); and mice
were perfused 4 weeks after TMX administration. The genetic
background of all mice is C57BL/6 J, except for the ChIP-seq
experiment conducted in PNCs from wild-type ICR embryos.
Experiments were conducted blind, and genotypes were
provided for statistical analyses. No animals were excluded
from the study. Every animal was used in a single experiment.
All the mice were maintained and bred in pathogen-free
conditions within the animal house at the Instituto de Neu-
rociencias (UMH-CSIC) with a 12-h light/dark cycle, constant
temperature (22 ± 1 °C) and relative humidity (55 ± 5%), with
free access to food and water. Experimental designs were
consistent with Spanish (BOE 34/11370-421, 2013) and
European Union Council (2010/63/EU) regulations and
approved by the Institutional Animal Care and Use
Committee.
Neuronal culture preparation and treatments
Primary hippocampal and cortical neurons were obtained
from E17.5 embryos. Hippocampus and cortex were dis-
sected and processed as described previously [31]. In the
experiments with Nestin-cKO and cWT PNCs, each embryo
was processed separately. In the experiment with ICR
embryos (ChIP-seq), all embryos were pooled together
before plating the cells. The day of plating was considered
day in vitro 1 (DIV1). In the rescue experiment with B-27™
Supplement (Gibco), the culture media used through the
whole experiment was prepared with different concentra-
tions of this reagent. In stimulation experiments, DIV10
cortical cultures were exposed to a mix of bicuculline (25
μM) and AP-4 (1 mM) for the indicated times. Chemical
long-term potentiation (cLTP) was induced in DIV16 hip-
pocampal cultures as described previosly [25]. In the
experiments involving lentivirus (LV) infection, hippo-
campal and cortical neurons from Nestin-cKO embryos
were infected at DIV3 and fixed for immunofluorescence
analysis or collected for RNA isolation, respectively, at
DIV10. LV-syn-VP16 and LV-syn-VP16-SRF were pro-
duced as described previously [31]. In Sholl analysis
experiments, the plasmid pDsRed-Express2-C1 (Clontech)
driving dsRed expression or pSyn-GFP driving GFP
expression were transfected using Lipofectamine 2000
(Invitrogen) at DIV9 and the cultures were fixed 1 day later.
In cLTP experiments, the plasmid pDsRed-Express2-C1
(Clontech) driving dsRed expression were transfected using
Lipofectamine 2000 (Invitrogen) at DIV14 and the cultures
were fixed at DIV16 for spine morphology analysis.
Immunocytochemistry, immunohistochemistry, and
image analysis
PNCs grown on glass coverslips were fixed and stained
with 4% paraformaldehyde in PBS (12 min), washed in PBS
and PBS−0.1% Triton X-100 (PBT) and incubated for 0.5 h
at room temperature with 3% newborn calf serum (NCS)-
PBT, as previously described [28]. Coverslips were incu-
bated overnight at 4 oC with the primary antibodies diluted
in 2% NCS-PBT. The primary antibodies used in immu-
nocytochemistry are α-MAP2 (Sigma, M9942), α-GFAP
(Sigma, G9269), α-GFP (Aves Labs, GFP-1020, valid also
for recognizing EYFP), α-CBP (A22, Sigma sc369), α-
AcH2A (K5, 9, 13, 15) (Sigma, 07-376), α-AcH4 (K5, 8,
12, 6), α-AcH3 (K9, 14), and α-AcH2B (K5, 12, 15, 20)
(generated in Barco’s lab [42]). In immunohistochemistry
experiments, mice were perfused with 4% paraformalde-
hyde in PBS as described previosly [28]. Coronal vibratome
sections (80-μm) were obtained from the brain of Nestin-
CreERT2:Crebbpf/f:tdTOM and Nestin-CreERT2:tdTOM
mice perfused 4 weeks after TMX administration. Brain
sections were washed in PBS and PBT and incubated for 30
min at room temperature with 3% NCS-PBT. The primary
antibodies used in immunohistochemistry are α-dsRed
(Clontech, 632496), α-Dcx (ab18723), and α-NeuN (Che-
micon MAB377). Neuronal cultures and brain slices were
both counterstained with a 1 nM DAPI solution (Invitrogen)
before mounting. Photos were taken with an Olympus
confocal inverted microscope or a Leica epifluorescence
microscope, except for the diaphragm images that were
taken with a Leica fluorescence stereomicroscope. For
whole-mount staining of mouse diaphragms, P0 pups were
perfused with 4% paraformaldehyde in PBS for 2 min.
Diaphragms were then dissected and washed in 0.1 M
glycine in PBS, blocked overnight in blocking buffer (0.5%
Triton X-100, 3% BSA in PBS) at 4 °C, and incubated
overnight in blocking buffer with primary α-Pan-axonal
neurofilament (1:1000, Covance #SMI-311R) also at 4 °C.
After several washes, samples were incubated overnight at
4 °C in blocking buffer with an Alexa-488 anti-mouse
antibody (1:500, Jackson ImmunoResearch). In the cell
counting experiments in Nes-iKOs, brain slices were con-
secutively numbered and four sections (taken 80 μm apart)
per animal were randomly selected. Confocal scans were
taken using the 20x objective (2-μm z-step; area= 0.72 mm
[2] per field containing the whole dentate gyrus, in total
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0.32 mm3, and keeping constant pinhole, contrast, and
brightness). Images were converted to green or red and
analyzed with ImageJ software. To calculate the percentage
of tdTOM/NeuN and tdTOM/Dcx double-positive cells, all
tdTOM cells in the granule cell layer and subgranular zone
in the z-stacks were counted. The number of double-
positive cells from four sections per mouse was divided by
the number of tdTOM cells in the same sections to calculate
a percentage value for each mouse (n= 3 mice per geno-
type). The images shown are reconstructions in z-stack with
the average intensity. For the analysis of spine density and
size, the program NeuronStudio was utilized as previously
described [25]. For Sholl analysis, the dendrites of trans-
fected neurons were drawn and analyzed with the Neuro-
lucida tracing Software (MBF Bioscience) in a blind
manner. The number of intersections was determined every
2 μm, starting at a radius of 5 μm from the center of the
neuronal soma. For the analysis of the length and number of
dendrites (Fig. 3h), we grouped the data into order ranges:
order 1–8, initial dendrites; order 9–16, intermedial den-
drites; and order 17–32 (or higher), terminal dendrites. The
level of histone acetylation in the PNCs was quantified by
intensity of fluorescence with ImageJ software after mark-
ing the nucleus area as region of interest (ROI).
MRI analyses
MRI analysis of P0 Nestin-cKOs and Crebbpf/f pups was car-
ried out in a horizontal 7T scanner with a 30-cm diameter bore
(Biospec 70/30 v, Bruker Medical, Ettlingen, Germany) as
previously described [43] with some modifications. T2-
weighted anatomical images were collected using a rapid
acquisition relaxation enhanced sequence (RARE), applying
the following parameters: 15 slices, 30 × 30mm field of view
(FOV), 1-mm slice thickness, 256 × 256 matrix, 56ms effec-
tive echo time (TEeff), 2 s repetition time (TR), and 8 RARE
factor. The B0 field distribution in a large voxel (40 × 40 × 40
mm3) containing the volume to be imaged was acquired
(FieldMap). Samples were localized with a T2-weighted
RARE sequence, and first- and second-order shims adjusted
with MAPSHIM application in a sufficiently large voxel con-
taining the brain. Three-dimensional data were acquired using a
RARE 3D sequence with 1500ms TR, 46.8ms TEeff, 16
RARE factor, and 16 averages in a total acquisition time of
13.6 h. The matrix size was 300 × 200 × 170 using a FOV of
30 × 20 × 17mm3, which yielded an isotropic resolution of
100 μm. Data were acquired and processed with
Paravision5.1 software. Image resolution was digitally
increased by linear interpolation rendering a final isotropic
resolution of 30 μm. Length and volume measurements
were performed using ImageJ software. Three-dimensional
reconstructions of MRI images were created with Imaris
software.
RNA extraction and RT-qPCR
Total RNA from tissue and hippocampal cultures was
extracted with TRI reagent (Sigma-Aldrich) and reverse
transcribed to cDNA using the RevertAid First-Strand
cDNA Synthesis kit (Fermentas). qPCR was performed in
an Applied Biosystems 7300 real-time PCR unit using Eva
Green qPCR reagent mix. The primer sequences used in
RT-qPCR assays are: Nptx2, forward: 5ʹ-GAACGCCCTG
CTGCAGAGv-3ʹ, reverse: 3ʹ-AATGCACTGTTGCCTCG




RNA-seq, ChIP-seq, and bioinformatical analyses
Cortical PNCs of 2 cWTs and 3 Nes-cKOs embryos were
treated or not with Bic and sequenced separately. The
10 samples were sequenced according to the manufacturer
instructions in a HiSeq 2500 sequencer (Illumina, Inc).
Briefly, RNA-seq reads were mapped to the mouse gen-
ome (Mus_musculus.GRCm.38.83) using STAR (v2.5.0c)
[44]. Quality control of the raw data was performed with
FastQC (http://www.bioinformatics.babraham.ac.uk/
projects/fastqc/). Library sizes were between 19 and 26
million single reads. Analysis and preprocessing of data
were performed using R (v3.4.3“Kite-Eating Tree”) sta-
tistical computing and graphics. Samtools (v1.3) were
used to handle BAM files [45]. To retrieve differentially
expressed genes (DEG), mapped reads were counted with
HTSeq v0.6.1 [46] and count tables were analyzed using
DeSeq2 v1.10.0, R-package [47] and bioconductor v3.2
(BiocInstaller 1.20.3). Genes were considered differen-
tially expressed at Benjamini–Hochberg (BH) adjusted
p-value < 0.1 and absolute log2-fold change > 1. Sig-
nificantly upregulated and downregulated genes were
visualized with IGV (v2.3.72) and clustering analysis.
Chromatin immunoprecipitation (ChIP) from PNCs was
performed as previously described using an anti-VP16
(Sigma V4388) antibody [43]. ChIP-seq was performed in
a HiSeq 2500 machine using Flow Cell v4 in single-end
configuration (50 bp). Quality control of the raw data was
performed with FastQC (http://www.bioinformatics.babra
ham.ac.uk/projects/fastqc/). Libraries were trimmed from
adapters and low-quality bases using Trimmomatic v0.36
[48], and mapped to reference genome (Ensembl
GRCm38) using Bowtie2 v2.3.2 [49]. Data were further
processed using samtools (v1.5) [45] and bedtools
(v2.26.0) [50]. Peak calling for ChIP-seq datasets was
performed using MACS2 (v2.1.1) [51], SeqMINER [52]
was used to generate the k-means clustering data and the
merged ChIP profiles. Further data processing was
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performed with custom scripts in the R programming
language (https://cran.r-project.org/). Data from ref. [30]
were lifted over from mm9 to mm10 using the R package
rtracklayer. GO enrichment analyses were performed
using the platform Panther [53]. TFBS enrichment ana-
lysis was conducted using the Enrichr website (http://amp.
pharm.mssm.edu/Enrichr/).
Statistical analyses
Statistical analysis was performed using Prism 6.0 software
(GraphPad). Sample size was decided based on previous
experience and the literature in this field. Comparison between
animals/pups are based on genotype, and no randomization
method was applied. In PNC experiments using different
treatments, wells were randomly assigned to the various
experimental conditions (unbiased protocol). Two-tailed Stu-
dent’s t tests were used to compare the means between the
samples and their respective controls. In Sholl analyses, the
statistical difference between genotypes were assessed by two-
way ANOVA (non-repeated measures). For pairwise compar-
ison of averages data were tested for normality. If any of the
two samples were significantly non-normal, a non-parametric
Mann–Whitney U/Wilcoxon rank-sum test was executed
instead. If the data from the two samples met the normality
criterion, an F test was used for equality of variances. The P-
values of Student’s t tests and two-way ANOVA are repre-
sented in the figures by asterisks (*P < 0.05, **P < 0.01,
***P < 0.001 and ****P < 0.0001). The absence of asterisk
indicates that the change relative to control was not statistically
significant.
Data availability
The RNA-seq and ChIP-seq datasets are available at the
GEO Series GSE118248.
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